Partnership for Part D Access
  • Home
  • About Us
    • Who We Are
    • Patient Communities
    • Our Leadership
  • The Issue
    • Six Protected Classes
    • History
  • Resources
  • Newsroom
  • Stakeholder Voices
  • Contact Us
  • Home
  • About Us
    • Who We Are
    • Patient Communities
    • Our Leadership
  • The Issue
    • Six Protected Classes
    • History
  • Resources
  • Newsroom
  • Stakeholder Voices
  • Contact Us

Resources

Partnership: New Report Highlights Access Challenges for Patients with Complex, Chronic Conditions

2/25/2021

 
Picture
​A new study from the Partnership for Part D Access confirms that the Medicare Part D protected classes policy is an essential pillar of protection for beneficiaries with complex health conditions. Yet, the research also highlights that Medicare prescription drug plans (PDPs) are increasingly limiting access to medications — even for patients with complex, chronic conditions. The study, performed by Avalere Health, a leading strategic advisory company, provides new insights into the various steps Medicare Part D plans are taking to manage utilization of medications covered under Medicare’s six protected classes policy. The protected classes policy is designed to ensure that Medicare beneficiaries with some of the most serious health conditions — cancer, HIV, epilepsy, mental illness, and those at risk of organ rejection, among others — have access to the full range of medicines recommended by their physician.


Read More

Over 130 Patient Groups Urge Becerra to Maintain Six Protected Classes Policy

2/25/2021

 
Picture
​The Partnership for Part D Access sent a letter today cosigned by 138 individual patient advocacy organizations to Department of Health and Human Services Secretary-designee the Honorable Xavier Becerra, highlighting the importance of Medicare’s six protected classes policy and urging the Biden administration to reject a late Trump administration proposal to eliminate the benefit


Read More

30 HIV Groups Call for Rescinding Part D Demo

2/22/2021

 
Picture
30 advocacy groups as part the Federal AIDS Policy Partnership (FAPP) are urging Health and Human Services (HHS) Secretary-designee Xavier Becerra to rescind a policy change from the Trump administration that would severely weaken access to life-saving HIV treatments. Their letter echoes a recent flood of complaints triggered by the new Center for Medicare and Medicaid Innovation (CMMI) Part D Payment Modernization (PDM) Model, concluding that impending changes to the Medicare Part D ‘six protected classes’ policy would exacerbate the difficulties experienced by the HIV/ AIDS community.

Read More

Please Act Now to Support Medicare's Essential Patient Protections

2/10/2021

 
Picture
​Under a dangerous last-minute proposal from the Trump administration, millions of patients may soon lose access to vital medications. Specifically, a proposed demonstration from the Center for Medicare and Medicaid Innovation (CMMI) would allow health plans to sharply scale back their coverage of drugs in Medicare’s six “protected classes” — a policy change that would have devastating consequences for patients. This hasty, deeply misguided program would severely jeopardize Medicare beneficiary access to medications used to manage complex conditions such as cancer, mental illness, HIV-AIDS, epilepsy, Parkinson’s, and organ transplantation.


Read More

Pharmacy Stakeholders to CMMI: Scrap Trump’s Last-Ditch Effort to Weaken Protected Classes

2/10/2021

 
Picture
​Nine leading pharmacy stakeholder groups penned a letter to the Acting Director of the Center for Medicare and Medicaid Innovation (CMMI) Amy Bassano urging the Biden administration to rescind the Trump administration’s last-minute attempt to weaken Medicare’s six protected classes policy.

Read More

Leading Medicare Advocacy Groups Urge HHS to Rescind Trump Part D Demo

2/9/2021

 
Picture

​​Two leading Medicare beneficiary advocacy groups have joined the chorus of stakeholders calling upon the President Joe Biden to take immediate action to rescind the Trump administration’s last-minute attempt to weaken coverage requirements for drugs within the six protected classes policy. 


Read More

    Author

    Write something about yourself. No need to be fancy, just an overview.

    Archives

    March 2021
    February 2021
    November 2020
    January 2020
    May 2019
    April 2019
    March 2019
    February 2019
    January 2019
    November 2018
    July 2018
    June 2018
    March 2018
    January 2018
    September 2017
    August 2016
    June 2016
    March 2016
    September 2014
    March 2014
    February 2014
    January 2014
    July 2011
    September 2010
    March 2010
    July 2008
    January 2008
    December 2003

    Categories

    All

    RSS Feed

Learn more

About Us
Patient Communities
​Issues
​Background

What's New?

​Newsroom
Resources
​

Contact

Contact Us
© COPYRIGHT 2018. ALL RIGHTS RESERVED.